Similar articles

• Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.

  Milgrom M, Kyriakides GK, Esquenazi V, Olson L, Miller J. Milgrom M, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):1873. Transplant Proc. 1987. PMID: 3274444 No abstract available.
• Skin test reactivity and lymphocyte subsets in cyclosporine versus azathioprine-treated renal transplant recipients.

  Pomer S, Daniel V, Dreikorn K, Röhl L. Pomer S, et al. Transplant Proc. 1987 Feb;19(1 Pt 2):1568-9. Transplant Proc. 1987. PMID: 3079026 Clinical Trial. No abstract available.
• Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.

  Jones RM, Murie JA, Allen R, Jaskowski A, Morris PJ. Jones RM, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):1926. Transplant Proc. 1987. PMID: 3274453 No abstract available.
• Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients.

  Davis RC, Nabseth DC, Olsson CA, Idelson BA, Schmitt GW, Cho SI, Mannick JA. Davis RC, et al. Transplant Proc. 1974 Dec;6(4 Suppl 1):67-70. Transplant Proc. 1974. PMID: 4612906 Review. No abstract available.
• Present status of kidney transplantation.

  Merrill JP. Merrill JP. Dis Mon. 1974 Nov:1-30. doi: 10.1016/s0011-5029(74)80011-8. Dis Mon. 1974. PMID: 4609705 Review. No abstract available.